Deals & Cases
Schellenberg Wittmer advises AOP Orphan Pharmaceuticals on its license agreement with Eagle Pharmaceuticals
09.08.2021
Schellenberg Wittmer assisted AOP Orphan Pharmaceuticals on its recent license agreement with Eagle Pharmaceuticals regarding U.S. rights for Landiolol, a beta blocker.
The team of Schellenberg Wittmer consisted of Philipp Groz and Prof. Dr. Peter Georg Picht (both Intellectual Property and Life Sciences) as well as Roland Mathys and Amalie Wijesundera (both Data Protection).
